PARP Drugs Help Some Breast Cancer Patients, But They’re No Magic Bullet
For patients with metastatic breast cancer, doctors don’t yet know how to predict long-term responses to this PARP drug.
A New PARP Drug For Breast Cancer? I’m Thrilled!
The paradigm for using chemo first to treat advanced breast cancer may change, as we gain experience with these new drugs.
3 Lessons From An Alarming Case Of Mistaken Cancer Gene Test Results And Surgery
Before choosing any treatment after genetic testing, hit the pause button. Ask questions. Get a second opinion.
A Pill Might Control Pancreatic Cancer, Even If It Doesn’t Cure It
A new type of cancer medication, called PARP inhibitors, is gaining traction in clinical practice.
A PARP Inhibitor Keeps Some Cancers In Check For Years
Lynparza—a PARP inhibitor taken as an oral tablet, daily— keeps qualified cases of advanced ovarian cancer in check for two years, as compared to placebo.
Why I’m Wary Of Grail And Its Plan To Develop A Cancer Detection Blood Test
My worry for Grail is that a lot of people will get worked up upon finding genetic changes of unknown significance. Meanwhile, it might fail to detect cancer in people who really have it.
Precision Medicine Is A Needed Goal That Will Benefit Cancer Patients
A common misconception is that precision medicine is about one drug for one disease. But for most cancer types, it will involve combining medications in effective cocktails.
Precision Medicine Will (Eventually) Lower Cancer Care Costs
Over time, the costs should drop, like for smartphone tech, what my Dad – a chemistry major and retired physician – called “magic.”
Lynparza, First In A New Class Of Cancer Drugs, Is Surprisingly Active In A Wide Range Of Tumors
So far, the studies demonstrate that Lynparza has activity in cancer patients with and without inherited BRCA mutations.
Chatting With Anne Parker: A Patient’s View On How Cancer Care Has Changed Since The 1960s
Anne Parker’s perspective on cancer care – as a family member, patient and advocate – spans over 50 years.
Understanding Angelina Jolie Pitt’s Cancer Risk And Her Decision To Tell About It
By telling her story, she helps break the mystery and stigma that deter honest and needed discussion about cancer-causing, inherited genetic mutations.
For Colon Cancer Screening, Cologuard Test Offers A Solid New Option
Getting checked, one way or another, has even been deemed cost-effective. The question for colorectal cancer, if you choose to be screened, is how: what’s the best method?
‘Lily,’ A Film About A Young Artist With Breast Cancer, And What’s Next In Her Life
What this movie gets right is the loneliness of having cancer – the feeling that kicks in when you’re awake and alive in some sort of hyper-sterile place receiving therapy, where there’s no one else.
The (Unmet) Potential Value of Cancer Genome Testing
Genome sequencing is not routine in oncology practice. But maybe it should be, advocates suggest.
Ambitious ‘Lung-MAP’ Trial Aims to Evaluate Biomarkers and New Drugs in Squamous Cell Lung Cancer
The Lung-MAP trial will identify molecular abnormalities in tumors specimens from thousands of patients with squamous cell lung cancer.
Don’t Judge Her
What’s great about this piece, and what’s wrong about it, is that it comes from an individual woman.
A Chip against Cancer: Microfluidics Spots Circulating Tumor Cells
With an ordinary blood sample, a device can monitor cancerous cells for spread or resistance to treatment.